Orexigen Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Orexigen Therapeutics's balance sheet done over the years? Its assets were worth $304,589,000 last year, which is more than in the previous period. 81% of Orexigen Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $247,545,000, which means an increase by 22% compared compared to last year.

Debt to Assets

Orexigen Therapeutics, Inc. (NASDAQ:OREX): Debt to assets
2013 180121000 138.25M 76.76%
2014 212981000 190.63M 89.51%
2015 236589000 203.21M 85.89%
2016 304589000 247.54M 81.27%

OREX Balance Sheet (2013 – 2016)

2016 2015 2014 2013
Assets
Current assets:
Cash and cash equivalents
92.49M155.42M104.24M98.12M
Short term investments
11.49M58.58M101.29M78.87M
Net receivables
1.10M6.82M2.57M77K
Inventory
23.19M10.80M1.19M0
Other current assets
96.17M2.25M2.02M1.20M
Total current assets
224.46M233.89M211.32M178.28M
Non-current assets:
Property, Plant and Equipment
1.04M1.28M857K630K
Goodwill
0000
Intangible assets
76.06M000
Long term investments
0000
Other non-current assets
-10.45M-6.99M251K-11.38M
Total non-current assets
80.12M2.69M1.65M1.83M
Total assets
304.58M236.58M212.98M180.12M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
4.73M9.61M8.22M3.42M
Short term debt
15M1.34M7.30M6.39M
Total current liabilities
65.36M32.24M29.71M22.85M
Non-current liabilities:
Long term debt
64.27M88.12M83.90M80.03M
Deferred tax
0000
Other non-current liabilities
0150K354K232K
Total non-current liabilities
83.62M179.37M160.92M128M
Total liabilities
247.54M203.21M190.63M138.25M
Data sourceData sourceData sourceData source